We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current WGS market cap is 551.29M. The company's latest EPS is USD -6.7464 and P/E is -3.14.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 61.35M | 43.14M | 49.04M | 53.3M | 57.42M |
| Operating Income | -114.74M | -58.24M | -51.62M | -34.35M | -37.75M |
| Net Income | -308.76M | -60.99M | -46.72M | -43.32M | -24.74M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 212.2M | 234.69M | 202.57M |
| Operating Income | -206k | -446.15M | -457.51M | -182.3M |
| Net Income | -192k | -245.39M | -548.98M | -175.77M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 490.94M | 545.3M | 476.39M | 417.29M | 418.76M |
| Total Liabilities | 237.24M | 216.83M | 180.28M | 163.03M | 190.74M |
| Total Equity | 253.71M | 328.47M | 296.11M | 254.26M | 228.02M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 444.14M | 554.09M | 490.94M | 418.76M |
| Total Liabilities | 15.59M | 165.99M | 237.24M | 190.74M |
| Total Equity | 5M | 388.1M | 253.71M | 228.02M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -319.16M | -55.56M | -109.06M | -150.29M | -180.15M |
| Investing | -141.33M | -462k | -11.73M | -38.86M | -43.73M |
| Financing | 197.32M | 132.66M | 140.05M | 139.14M | 186.24M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -386k | -190.43M | -319.16M | -180.15M |
| Investing | -442.75M | -20.79M | -141.33M | -43.73M |
| Financing | 444.23M | 493.73M | 197.32M | 186.24M |
| Market Cap | 551.29M |
| Price to Earnings Ratio | -3.14 |
| Price to Sales Ratio | 2.72 |
| Price to Cash Ratio | 5.53 |
| Price to Book Ratio | 2.42 |
| Dividend Yield | - |
| Shares Outstanding | 26.05M |
| Average Volume (1 week) | 835.28k |
| Average Volume (1 Month) | 921.45k |
| 52 Week Change | 200.14% |
| 52 Week High | 23.79 |
| 52 Week Low | 1.16 |
| Spread (Intraday) | 1.45 (6.17%) |
| Company Name | GeneDx Holdings Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.genedx.com |
| Industry | health services (8000) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
